Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07187349 · ClinicalTrials.gov registry record
Real World Assessment of Resistance Breathing Device
A clinical trial, sponsored by Livotion.
- Completed
- Registry status
- 73
- Enrollment target
NCT07187349: Completed study, sponsored by Livotion.
NCT07187349 is a clinical trial that has completed, run by Livotion. The registered enrollment target is 73 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07187349 has completed, sponsored by Livotion.
- COMPLETED
- Registry status
- 73 participants
- Enrollment target
Study Summary
The purpose of this study is to examine the usability and effectiveness of a stress management device during an academic exam period and asks the following questions: * To what extent is a resistance breathing device (AIRpen) utilized by participants during the study period? * What impact does utilizing a resistance breathing device have on participant's well-being when used during a stressful academic period? * To what extent is a diaphragmatic breathing device acceptable for use when utilized during a noted stress-inducing period such as academic examinations?
Primary Outcome
The System Usability Scale is a 10-item measure that address the usability and learnability of a system. The SUS has been modified to reflect the AIRpen intervention. Statements are ranked on a Likert scale for 1-5, with 1 indicating "Strongly Disagree" and 5 indicating "Strongly Agree". Raw scores are converted into a final score that ranges from 0-100, with a larger score indicating greater usability.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 73 participants |
| Start Date | 2025-12-01 |
| Est. Completion | 2026-01-05 |
What the finished NCT07187349 record still lists
NCT07187349 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 73 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT07187349 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07187349 about?
NCT07187349 is a clinical study titled "Real World Assessment of Resistance Breathing Device". The purpose of this study is to examine the usability and effectiveness of a stress management device during an academic exam period and asks the following questions: * To what extent is a resistance breathing device (AIRpen) utilized by participants during the study period? * What impact does util...
What is the current status of trial NCT07187349?
This trial is currently completed. The enrollment target is 73 participants. The study started on 2025-12-01. Estimated completion is 2026-01-05.
Who is sponsoring clinical trial NCT07187349?
This trial is sponsored by Livotion, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03661307 · 73 participants · Phase 1
Quizartinib, Decitabine, and Venetoclax in Treating Participants With Untreated or Relapsed Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
- NCT05386108 · 73 participants · Phase 1
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
- NCT05961592 · 73 participants · Phase 1
R-2487 in Patients With Rheumatoid Arthritis
- NCT06150664 · 73 participants · Phase 1
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI